George R Nahass

Mr. George R Nahass


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 March 2025 in AI and Ethics
Verified
Journal Article
Closed access
PDF file
JKJeff J. H. Kim
Jeff J. H. Kim
JSJunyoung Soh
Junyoung Soh
SKShrinidhi Kadkol
Shrinidhi Kadkol
ISItay Solomon
Itay Solomon
HYHyelin Yeh
Hyelin Yeh
OAOlusola Ajilore
Olusola Ajilore

20 January 2025 in arXiv
Verified
Preprint
Open access
PDF file
JKJeff J. H. Kim
Jeff J. H. Kim
GNGeorge R Nahass
George R Nahass
YDYang Dai
Yang Dai
TTTheja Tulabandhula
Theja Tulabandhula
Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality, with lung metastases being the most common site of distant spread and significantly worsening prognosis. Despite the growing availability of clinical and demographic data, predictive models for lung metastasis in HCC remain limited in scope and clinical applicability. In this study, we develop and validate an end-to-end machine learning pipeline using data from the Surveillance, Epidemiology, and End Results (SEER) database. We evaluated three machine learning models (Random Forest, XGBoost, and Logistic Regression) alongside a multilayer perceptron (MLP) neural network. Our models achieved high AUROC values and recall, with the Random Forest and MLP models demonstrating the best overall performance (AUROC = 0.82). However, the low precision across models highlights the challenges of accurately predicting positive cases. To address these limitations, we developed a custom loss function incorporating recall optimization, enabling the MLP model to achieve the highest sensitivity. An ensemble approach further improved overall recall by leveraging the strengths of individual models. Feature importance analysis revealed key predictors such as surgery status, tumor staging, and follow up duration, emphasizing the relevance of clinical interventions and disease progression in metastasis prediction. While this study demonstrates the potential of machine learning for identifying high-risk patients, limitations include reliance on imbalanced datasets, incomplete feature annotations, and the low precision of predictions. Future work should leverage the expanding SEER dataset, improve data imputation techniques, and explore advanced pre-trained models to enhance predictive accuracy and clinical utility.

19 February 2025 in International Journal of Computer Assisted Radiology and Surgery
Verified
Journal Article
Closed access
PDF file
GNGeorge R Nahass
George R Nahass
NKNicolas Kaplan
Nicolas Kaplan
ISIsabel M Scharf
Isabel M Scharf
DSDevansh Saini
Devansh Saini
NZNaji Bou Zeid
Naji Bou Zeid
LALee W. T. Alkureishi
Lee W. T. Alkureishi